Novadip Biosciences SA announces first pediatric patient with congenital pseudoarthrosis of the tibia undergoes implantation with NVD-003, an autologous tissue regeneration product, in Phase 1b/2a US/EU clinical trial Trellis Bioscience announces positive interim Phase 1 results for TRL1068, a novel native human monoclonal antibody which reduces bacterial biofilm burden in chronic prosthetic joint infections Paragraf acquires Cardea Bio to extend graphene electronics leadership VUV Analytics announces $20 million financing ProterixBio announces commercial offering of Quantitative Soluble ST2 Assay Picocom and Antevia Networks collaborate to provide new innovative 5G in-building solutions for enterprise private networksBack To News
October 17, 2017
Acquired by C.R. Bard. Developer of endovascular devices for the treatment of coronary and peripheral CTO.